AGM
PYXS icon

Alpine Global Management’s Pyxis Oncology PYXS Stock Holding History

Alpine Global Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-115,514
Closed -$382K – 395
2024
Q2 		$382K Buy
+115,514
New +$486K 0.07% 209

Other funds holding PYXS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Alpine Global Management's PYXS Position: Q3 2024 in Review

Alpine Global Management sold out of Pyxis Oncology (PYXS) in Q3 2024, closing a stake of 115,514 shares — an estimated $382K sold.

Alpine Global Management first reported a position in PYXS in Q2 2024 and held it in 1 quarter. The position peaked at $382K in Q2 2024. 92 funds tracked by Wall St. Rank hold PYXS as of Q3 2024.

  • Alpine Global Management reported no remaining Pyxis Oncology position as of Q3 2024 after selling out during the quarter.
  • Alpine Global Management sold 115,514 Pyxis Oncology shares in Q3 2024, an estimated $382K.
  • Alpine Global Management first reported a position in Pyxis Oncology in Q2 2024 and held it in 1 quarter.
  • Alpine Global Management's Pyxis Oncology position peaked at $382K in Q2 2024.
  • 92 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.